Cellectis（NASDAQ: CLLS）報告季度每股虧損爲$(0.16)，優於分析師的共識預期$(0.17)，超出5.88%。相比去年同期每股虧損$(0.57)，這是一增長了71.93%。公司報告季度銷售額爲3322萬美元，超出分析師的共識預期945萬美元，超出251.59%。相比去年同期銷售額199萬美元，增長了1.57千%。

以上內容來自Benzinga Earnings專欄，原文如下：

Cellectis (NASDAQ:CLLS) reported quarterly losses of $(0.16) per share which beat the analyst consensus estimate of $(0.17) by 5.88 percent. This is a 71.93 percent increase over losses of $(0.57) per share from the same period last year. The company reported quarterly sales of $33.22 million which beat the analyst consensus estimate of $9.45 million by 251.59 percent. This is a 1.57K percent increase over sales of $1.99 million the same period last year.